Becton, Dickinson and Company (BDX)
| Market Cap | 64.04B |
| Revenue (ttm) | 20.18B |
| Net Income (ttm) | 1.71B |
| Shares Out | 289.12M |
| EPS (ttm) | 5.86 |
| PE Ratio | 37.74 |
| Forward PE | 15.41 |
| Dividend | $4.16 (1.88%) |
| Ex-Dividend Date | Dec 9, 2024 |
| Volume | 191,736 |
| Open | 221.38 |
| Previous Close | 221.04 |
| Day's Range | 221.11 - 221.95 |
| 52-Week Range | 218.75 - 249.89 |
| Beta | 0.42 |
| Analysts | Strong Buy |
| Price Target | 283.50 (+28.0%) |
| Earnings Date | Feb 6, 2025 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for BDX stock is "Strong Buy." The 12-month stock price forecast is $283.5, which is an increase of 28.00% from the latest price.
News
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance He...
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style
The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Divid...
These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More
With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will t...
17 Upcoming Dividend Increases, Including A King
With the holiday season underway, I present 17 companies with dividend increases for 2024, including Becton, Dickinson, and Company, a dividend king with a 52-year streak. My strategy focuses on buyin...
Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript)
Becton, Dickinson and Company (NYSE:BDX) 7th Annual Evercore ISI HealthCONx Results Conference December 3, 2024 10:50 AM ET Company Participants Richard Byrd - EVP and President of Interventional Bus...
VPL Welcomes Mark Longley as Chief Executive Officer; Eric McGlade, CEO and Co-Founder, Named Chairman of the Board
WESTERVILLE, Ohio--(BUSINESS WIRE)-- #HealthcareLogistics--Vantage Point Logistics ("VPL") announced today that Mark Longley will join the company as its Chief Executive Officer.
My Best Dividend Aristocrats For December 2024
The ProShares S&P 500 Dividend Aristocrat ETF is up 10.26% year-to-date through October. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 40 mon...
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
BROWNSVILLE, Texas , Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved co...
BD to Present at the 7th Annual Evercore ISI HealthCONx Conference
FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual...
Becton, Dickinson and Company Q4: Shifting To High-Growth Areas
Becton, Dickinson and Company is projected to achieve 8.8%-9.3% revenue growth in FY25, driven by new product launches and the APM business. The acquisition of Edwards Lifesciences' Critical Care prod...
Becton, Dickinson and Company (BDX) Q4 2024 Earnings Call Transcript
Becton, Dickinson and Company (NYSE:BDX) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer & Head of Investor Relations...
Becton Dickinson beats quarterly estimates on strength in drug-delivery devices
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices.
BD Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
Strong Growth and Margin Execution Drives Performance in Quarter Q4 revenue of $5.4 billion increased 6.9% as reported, 7.4% currency-neutral and 6.2% organic Q4 GAAP and adjusted diluted EPS from con...
BD Board Increases Dividend for 53rd Consecutive Year
FRANKLIN LAKES, N.J. , Nov. 7, 2024 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of...
Becton, Dickinson And HP Among 13 Companies To Announce Annual Dividend Increases In First Half Of November
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. I expect 13 companies to announce their annual increases i...
BD Launches Enhanced Intraosseous System, Enabling Vascular Access in Seconds for Critical Care Situations
FRANKLIN LAKES, N.J. , Oct. 30, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched the new BD® Intraosseous Vascular Acces...
My Best Dividend Aristocrats For November 2024
The ProShares S&P 500 Dividend Aristocrats ETF went on a great run during Q3, gaining 11.6% during the quarter. I present 3 strategies that can theoretically beat the dividend aristocrat index in the ...
BD Named Among the 100 Best Corporate Citizens of 2024
FRANKLIN LAKES, N.J. , Oct. 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has been named as one of the 100 Be...
Why These 2 Dividend Aristocrats Look Like Buys Today
Twenty-five consecutive years of dividend growth and economic moats work in these undervalued stocks' favor. 00:00 Introduction 01:02 Chevron CVX 01:37 Becton Dickinson BDX Susan Dziubinski: I'm Susan...
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research
Automation-Ready Reagents Used with the Hamilton Robotics Liquid-Handler Streamlines and Helps Accelerate Lab Work Leading to Genomic Sequencing FRANKLIN LAKES, N.J. , Oct. 14, 2024 /PRNewswire/ -- B...
BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
Announces Dates for Fiscal 2025 Quarterly Earnings Webcasts FRANKLIN LAKES, N.J. , Oct. 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology com...
Undervalued Dividend Kings: October 2024
Dividend Kings have a 50+ year track record of increasing dividends, showcasing resilience through economic challenges. I rank Dividend Kings by quality score and highlight undervalued stocks for pote...
BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
No admission of liability or wrongdoing; settlement structured to eliminate uncertainty for all stakeholders related to settled cases. Settlement amount within current product litigation reserve and w...
My Best Dividend Aristocrats For October 2024
The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aris...
New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion
FRANKLIN LAKES, N.J. , Sept. 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new data that highlights how its adva...